AGR3 in Breast Cancer : Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection

to connected objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
In: 10.1371/journal.pone.0122106

Event
Veröffentlichung
(where)
Aachen
(who)
Universitätsbibliothek der RWTH Aachen
(when)
2015
Creator
Garczyk, Stefan
Stillfried, Saskia von
Antonopoulos, Wiebke
Hartmann, Arndt
Schrauder, Michael G.
Fasching, Peter A.
Anzeneder, Tobias
Tannapfel, Andrea
Ergönenc, Yavuz
Knüchel, Ruth
Rose, Michael
Dahl, Edgar

DOI
10.18154/RWTH-2015-02749
URN
urn:nbn:de:101:1-2018110506012835524678
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:49 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Garczyk, Stefan
  • Stillfried, Saskia von
  • Antonopoulos, Wiebke
  • Hartmann, Arndt
  • Schrauder, Michael G.
  • Fasching, Peter A.
  • Anzeneder, Tobias
  • Tannapfel, Andrea
  • Ergönenc, Yavuz
  • Knüchel, Ruth
  • Rose, Michael
  • Dahl, Edgar
  • Universitätsbibliothek der RWTH Aachen

Time of origin

  • 2015

Other Objects (12)

AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection

AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection

Invasive Breast Cancer: Recognition of Molecular Subtypes

Invasive Breast Cancer: Recognition of Molecular Subtypes

Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement

Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement

CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer

CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer

P53 regulated microRNAs in colorectal cancer

Hochschulschrift

P53 regulated microRNAs in colorectal cancer

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients

Mammographic texture as new and independent breast cancer risk factor

Hochschulschrift

Mammographic texture as new and independent breast cancer risk factor

Promoting-Activity-Test : mitogene Wirkung von Xenobiotika als Indikator ihrer tumorigenen Potenz in einem In-vivo-Kurzzeittestsystem

Hochschulschrift

Promoting-Activity-Test : mitogene Wirkung von Xenobiotika als Indikator ihrer tumorigenen Potenz in einem In-vivo-Kurzzeittestsystem

Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening

Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening

The role and prognostic relevance of CD68+ macrophages and DNMT3B in colon carcinomas

The role and prognostic relevance of CD68+ macrophages and DNMT3B in colon carcinomas

Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer

Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer

The Ability of Radiomics from PET/CT in Predicting the Status of PD-L1 Expression and KRAS Mutation in Non-Small Cell Lung Cancer

The Ability of Radiomics from PET/CT in Predicting the Status of PD-L1 Expression and KRAS Mutation in Non-Small Cell Lung Cancer

Related objects